Indonesia Molecule Institute (IMI) Introduces Hydrogen Nanobubble Therapy at Universitas Katolik Widya Mandala Surabaya 10:01, 26 March 2025 by admin
The Initiation of Intravenous Hydrogen Nano Bubble Injection and Its Phase 3 Clinical Trials for Parkinsonism Patients, as well as Its Future Benefits 14:43, 03 February 2025 by admin
High Unemployment of College Graduates: Time to Build Innovation-Based Industry 13:14, 07 January 2025 by admin
IMI and RAHO Club Introduce Hydrogen Nano Bubbles and Gasotransmitter to FK-KMK UGM: A Step Toward Health Revolution 15:38, 11 December 2024 by admin
Comprehensive Clinical Evaluation and Therapeutic Progression of a 70-Year-Old Female Following Ischemic Infarction: A Case Study in Integrated Pharmacotherapy and Intravenous Oxyhydrogen-Nitric Oxide Nanobubble Intervention 13:39, 30 September 2026 by admin
Reduction of Coronary Artery Stenosis Following Oxyhydrogen and Gasotransmitter Nanobubble Infusions: A Case Report 15:51, 16 September 2026 by admin
Oxyhydrogen nanobubbles attenuate angiogenesis, inflammation, and immunosuppression in Wistar rats hepatocellular carcinoma model 15:44, 16 September 2026 by admin
Hydrogen Nanobubble Therapy and Chronic Coronary Artery Disease: Lessons from a Case Report 13:40, 03 September 2026 by admin
